Yamagata, Kaoru
Nakayamada, Shingo
Tanaka, Yoshiya
Funding for this research was provided by:
the Ministry of Health, Labor and Welfare of Japan
the Ministry of Education, Culture, Sports, Science and Technology of Japan
Japan Agency for Medical Research and Development
the University of Occupational and Environmental Health, Japan
Article History
Received: 14 December 2017
Accepted: 26 February 2018
First Online: 12 March 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Y. Tanaka, has received consulting fees, speaking fees, and/or honoraria from Daiichi-Sankyo, Astellas, Pfizer, Mitsubishi-Tanabe, Bristol-Myers, Chugai, YL Biologics, Eli Lilly, Sanofi, Janssen, UCB and has received research grants from Mitsubishi-Tanabe, Takeda, Bristol-Myers, Chugai, Astellas, Abbvie, MSD, Daiichi-Sankyo, Pfizer, Kyowa-Kirin, Eisai, Ono. S. Nakayamada, has received speaking fees from Bristol-Myers, UCB, Astellas, Abbvie, Eisai, Pfizer, Takeda and has received research grants from Mitsubishi-Tanabe, Novartis and MSD. K. Yamagata declares no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.